SCHEMBL19239504

SCHEMBL19239504

CCN1C(=O)c2c(Br)c(Br)c3c4c(c(Br)c(Br)c(c24)C1=O)C(=O)N(CC)C3=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 5/20 0.45
F2 P00734 1/20 0.42
ELANE P08246 1/20 0.42
CTSG P08311 1/20 0.42
CTRC Q99895 1/20 0.42
ALDH1A1 P00352 5/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
GMNN O75496 1/20 0.37
THPO P40225 1/20 0.37
BLM P54132 1/20 0.37
PMP22 Q01453 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MGLL Q99685 1/20 0.37
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17682019 0.92 CYP1B1 (0.41) CYP1B1F2ELANECTSGCTRC
SCHEMBL3692053 0.88 F2 (0.43) CYP1B1F2ELANECTSGCTRC
SCHEMBL17679328 0.82 CA12 (0.36) CYP1B1ALDH1A1MAPTMAPK1MEN1
SCHEMBL6847144 0.77 CYP1B1 (0.36) CYP1B1F2ELANECTSGCTRC
SCHEMBL13578733 0.76 F2 (0.42) CYP1B1F2ELANECTSGCTRC
SCHEMBL19239503 0.76 F2 (0.42) CYP1B1F2ELANECTSGCTRC
SCHEMBL18136093 0.76 PTGS1 (0.48) ALDH1A1MGLLHSD17B10HPGDTSHR
SCHEMBL16311238 0.76 PTGS1 (0.48) ALDH1A1MGLLHSD17B10HPGDTSHR
SCHEMBL16208290 0.76 CA12 (0.33) ALDH1A1MAPTMAPK1MEN1KMT2A
SCHEMBL15501088 0.74 CYP1B1 (0.40) CYP1B1F2ELANECTSGCTRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170250347-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM BASF SE (DE) 2017-08-31 US disclosed
US-20170237005-A1 PROCESS FOR PREPARING A CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL BASF SE (DE) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250347-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM CRY1, NEFM, OR10J3 CYP1B1 4419/4885F2 3863/4885ELANE 2901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.